ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

PALI Palisade Bio Inc

4,82
0,00 (0,00%)
Pré-mercado
Última atualização: 05:00:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Palisade Bio Inc PALI NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 4,82 05:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,82
mais cotações »

Notícias Recentes

Data Hora Fonte Título
21/05/202409:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
14/05/202409:05GLOBEPalisade Bio Reports First Quarter 2024 Financial Results..
07/05/202409:30GLOBEPalisade Bio Appoints Margery Fischbein to its Board of..
07/05/202408:30GLOBEPalisade Bio Announces Closing of $4 Million Private..
02/05/202409:30GLOBEPalisade Bio Announces $4 Million Private Placement Priced..
01/05/202409:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
23/04/202409:30GLOBEPalisade Bio Enters into Strategic Collaboration with Strand..
16/04/202409:30GLOBEPalisade Bio Successfully Demonstrates Bioactivation of..
11/04/202410:15GLOBEPalisade Bio to Participate in the Virtual Investor Lunch..
10/04/202409:15GLOBEPalisade Bio Presents Development Overview of PALI-2108 at..
03/04/202418:30GLOBEPalisade Bio Announces 1-for-15 Reverse Stock Split
27/03/202409:00GLOBEPalisade Bio Reports Year End 2023 Financial Results and..
15/02/202410:35GLOBEPalisade Bio to Present at Digestive Disease Week (DDW) 2024
13/02/202410:35GLOBEPalisade Bio Provides Corporate Update and Reiterates..
08/02/202416:40GLOBECorrection Notice of Palisade Bio’s Press Release Announcing..
08/02/202410:05GLOBEPalisade Bio Announces Formation of Clinical Advisory Board..
30/01/202411:25GLOBEPalisade Bio Announces Exercise of Previously Issued..
29/01/202410:05GLOBEPalisade Bio Announces Positive Preclinical Data of Lead..
09/01/202410:00GLOBEPalisade Bio Selected for Poster Presentation at the 2024..
28/12/202310:00GLOBEPalisade Bio Announces Receipt of Second Milestone Payment..
10/11/202310:05GLOBEPalisade Bio Reports Third Quarter 2023 Financial Results..
11/10/202310:05GLOBEPalisade Bio to Participate at the Virtual Investor Ask the..
11/09/202317:01GLOBEPalisade Bio Announces Closing of $2 Million Registered..
11/09/202309:35GLOBEPalisade Bio Appoints GI Clinical Expert and Biotech..
07/09/202309:30GLOBEPalisade Bio Announces $2 Million Registered Direct Offering..
06/09/202309:45GLOBEPalisade Bio Transforms GI-Focused Pipeline Through..
11/08/202309:05GLOBEPalisade Bio Reports Second Quarter 2023 Financial Results
09/08/202309:05GLOBEPalisade Bio Announces Topline Results from U.S. Phase 2..
05/07/202309:45GLOBEPalisade Bio Announces Completion of Enrollment in LB1148..
22/06/202309:30PRNCAPALISADES ANNOUNCES NEW FOUND MAKES NEW HIGH-GRADE, AT..
14/06/202309:45GLOBEPalisade Bio Participate in the Healthcare Virtual..